Abstract:Statins are 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase inhibitors widely used in the treatment of hyperlipidemia. The inhibition of HMG-CoA reductase in the mevalonate pathway leads to the suppression of cell proliferation and induction of apoptosis. The cyclic GMP-AMP synthase (cGAS) stimulator of the interferon genes (STING) signaling pathway has been suggested to not only facilitate inflammatory responses and the production of type I interferons (IFN), but also activate other cellular processes, such as apoptosis. It has not been studied, however, whether cGAS-STING activation is involved in the apoptosis induced by statin treatment in human colorectal cancer cells. In this study, we reported that lovastatin impaired mitochondrial function, including the depolarization of mitochondrial membrane potential, reduction of oxygen consumption, mitochondrial DNA (mtDNA) integrity, and mtDNA abundance in human colorectal cancer HCT116 cells. The mitochondrial dysfunction markedly induced ROS production in mitochondria, whereas the defect in mitochondria respiration or depletion of mitochondria eliminated reactive oxygen species (ROS) production. The ROS-induced oxidative DNA damage by lovastatin treatment was attenuated by mitochondrial-targeted antioxidant mitoquinone (mitoQ). Upon DNA damage, mtDNA was released into the cytosol and bound to DNA sensor cGAS, thus activating the cGAS-STING signaling pathway to trigger a type I interferon response. This effect was not activated by nuclear DNA (nuDNA) or mitochondria RNA, as the depletion of mitochondria compromised this effect, but not the knockdown of retinoic acid-inducible gene-1/melanoma differentiation-associated protein 5 (RIG-I/MDA5) adaptor mitochondrial antiviral signaling protein (MAVS). Moreover, lovastatin-induced apoptosis was partly dependent on the cGAS-STING signaling pathway in HCT116 cells as the knockdown of cGAS or STING expression rescued cell viability and mitigated apoptosis. Similarly, the knockdown of cGAS or STING also attenuated the antitumor effect of lovastatin in the HCT116 xenograft model in vivo. Our findings suggest that lovastatin-induced apoptosis is at least partly mediated through the cGAS-STING signaling pathway by triggering mtDNA accumulation in the cytosol in human colorectal cancer HCT116 cells.

Mevalonate Prevents Lovastatin-Induced Apoptosis in Medulloblastoma Cell Lines

Statins enhance anti-tumro effect of sub reoylanilide hydroxamic acid on human non-small cell lung carcinoma cells

Lovastatin Induces Apoptosis of HepG-2 Cells by Activating ROS-dependent Mitochondrial and ER Stress Pathways.

HMG-CoA Reductase Inhibitors Induce Apoptosis of Lymphoma Cells by Promoting ROS Generation and Regulating Akt, Erk and P38 Signals Via Suppression of Mevalonate Pathway.

Inhibition of Proliferation and Induction of Apoptosis by Simvastatin in K562 Le Ukemic Cell Line

Quantitative Proteomic Analysis Revealed Lovastatin-Induced Perturbation of Cellular Pathways in Hl-60 Cells

Lovastatin-Induced Mitochondrial Oxidative Stress Leads to the Release of mtDNA to Promote Apoptosis by Activating cGAS-STING Pathway in Human Colorectal Cancer Cells

Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial Cells

[Effects of Clinically Effective Dose of Lovastatin on Prostate Cancer PC3 Cells].

Apoptosis Induced by Simvastatin in Rat Vascular Smooth Muscle Cells Through Calpain and Caspase-3-dependent Pathways

Activation of C-Jun N-Terminal Kinase is Required for Mevastatin-Induced Apoptosis of Salivary Adenoid Cystic Carcinoma Cells

Inducing Effect of Lovastatin on Apoptosis in Hela and HCT116 Cells

Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway.

Lovastatin inhibits apoptosis of mesenchymal stem cells isolated from rat bone marrow

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

Effects of fluvastatin on proliferation and apoptosis of HL-60 cells

Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.

Simvastatin inhibit proliferation in vascular smooth muscle cells in association with induction of PTEN and p27

Mevalonate Inhibits Acid Sphingomyelinase Activity, Increases Sphingomyelin Levels and Inhibits Cell Proliferation of HepG2 and Caco-2 Cells

Lovastatin Inhibits Cell Proliferation and Migration in Cholangiocarcinoma Cell Line QBC939

Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer